# Real-world outcomes of tumour necrosis factor inhibitor (TNFi) cyclers versus mechanism-of-action switchers among ulcerative colitis patients who failed first-line TNFi

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-outcomes-of-tumour-necrosis-factor-inhibitor-tnfi-cyclers-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Navneet Upadhyay,Amita Ketkar,Can Mert,Alexandra Wallem,Simin Baygani,Tariku J. Beyene,Deborah A. Fisher,Tracey Quimbo,Raven Perez,Michael Grabner,J. Casey Chapman |
| Citations | 0 |
| DOI | 10.1186/s12876-026-04829-y |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1186/s12876-026-04829-y |
| OpenAlex ID | https://openalex.org/W7165356404 |
| PMID | 42323583 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Can Mert](https://scholariq.org/researchers/can-mert/)

## Paper journal

- [BMC Gastroenterology](https://scholariq.org/journals/bmc-gastroenterology/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Immune Response and Inflammation](https://scholariq.org/topics/immune-response-and-inflammation/)
- [Macrophage Migration Inhibitory Factor](https://scholariq.org/topics/macrophage-migration-inhibitory-factor/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.